DEEP PALIKHEL: Open Payments
NPI 1053791079 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,638 in 59 payments from 14 companies in 2025. Trend: 2023 $1,227 · 2024 $1,440 · 2025 $1,638
Food & beverage: $1,638
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $321 |
| Ferring Pharmaceuticals Inc. | 8 | $243 |
| Inspire Medical Systems, Inc. | 1 | $180 |
| Aimmune Therapeutics, Inc. | 6 | $151 |
| CSL Behring | 5 | $143 |
| Alexion Pharmaceuticals, Inc. | 6 | $136 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66 |
| ABBVIE INC. | 2 | $61 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $56 |
Products named: VYNDAQEL, REBYOTA, INSPIRE, VOWST, Kcentra, ULTOMIRIS, XIFAXAN, JARDIANCE.
Industry payments across TX — which companies pay providers there.
